Clinical trial
SwissNET - a Prospective Registry of Patients With Neuroendocrine Tumours in Switzerland
NCT01039922 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SwissNET - a Prospective Registry of Patients With Neuroendocrine Tumours in Switzerland
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 31, 2008
- Completion date
- August 31, 2025
- Enrollment
- 1,245 (estimated)
- Sites
- 55
Conditions
As the registry lists them; a condition with its own page is linked.